跳转至内容
Merck
CN

主要文件

查看所有文档

333778

尿嘧啶-15N2

98 atom % 15N

别名:

2,4(1H,3H)-Pyrimidinedione-1,3-15N2

登录 查看组织和合同定价。

关于此项目

经验公式（希尔记法）:
C4H415N2O2
化学文摘社编号:
5522-55-4
分子量:
114.07
UNSPSC Code:
12352202
PubChem Substance ID:
24860179
MDL number:
MFCD00075013
Isotopic purity:
98 atom % 15N
Mass shift:
M+2
Form:
solid

isotopic purity

98 atom % 15N

Quality Level

200

form

solid

mp

>300 °C (dec.) (lit.)

mass shift

M+2

SMILES string

O=C1[15NH]C=CC(=O)[15NH]1

InChI

1S/C4H4N2O2/c7-3-1-2-5-4(8)6-3/h1-2H,(H2,5,6,7,8)/i5+1,6+1

InChI key

ISAKRJDGNUQOIC-MPOCSFTDSA-N

Packaging

This product may be available from bulk stock and can be packaged on demand. For information on pricing, availability and packaging, please contact Stable Isotopes Customer Service.

存储类别

11 - Combustible Solids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品

此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
EK1271
22128HA
071H3756
IG1332
SB0929

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Ken Shiraiwa et al.
Scientific reports, 11(1), 3132-3132 (2021-02-06)
Combination therapy of tegafur/uracil (UFT) and leucovorin (LV) is widely used to treat colorectal cancers. Although this therapy has a significant therapeutic effect, severe adverse effects occur frequently. Therapeutic drug monitoring (TDM) may help to prevent adverse effects. A useful